Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Clinical Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

NCT06644118 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.

NCT NCT06644118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06644118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Clinical Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
Lead sponsor
Zhejiang University
Phase
Phase 1
Overall status
Recruiting
Start date
October 23, 2024
Completion date
October 31, 2028
Enrollment
58 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma